Browsing Tag
Pain Away
3 posts
Wellnex Life completes A$19.8m Pain Away sale and becomes a very different healthcare business
Wellnex Life Limited has completed the Pain Away divestment for A$19.8 million upfront and up to A$1.5 million more, trading a major revenue contributor for debt reduction, liquidity and a smaller capital-light healthcare model.
September 15, 2026
Wellnex Life (ASX: WNX) wins vote for A$21.3m Pain Away sale and debt exit
Wellnex Life shareholders have approved the sale of Pain Away to Mentholatum Australasia for up to A$21.3 million, clearing a key condition for a transaction expected to eliminate approximately A$10.2 million of borrowings but also remove more than half of FY26 group revenue.
September 9, 2026
Wellnex Life sees 89% revenue surge as UK dual listing nears completion
Wellnex Life Limited is approaching a pivotal moment in its corporate strategy, reporting an 89% year-over-year increase in…
March 16, 2025